Research Confirms Safety of Pain Relievers During Pregnancy
Contrary to certain high-profile claims, taking pain relievers such as paracetamol during pregnancy has been deemed safe by a team of European scientists. The researchers conducted a thorough review of data following alleged connections to autism.
The study was published in a reputable medical journal dedicated to obstetrics, gynaecology, and women's health. The researchers focused on gathering the most reliable evidence to dispel the unfounded claims.
Paracetamol: A Reassuring Finding
The lead scientist of the study, a professor of obstetrics and maternal fetal medicine at a prominent London university, confidently proclaimed, "Paracetamol is safe to use in pregnancy." She asserted that the most important takeaway from their research is reassurance. When used as directed, there is no substantial evidence linking the use of paracetamol with autism, ADHD (attention-deficit/hyperactivity disorder), or intellectual disability.
The professor stated that she had been queried about this widely used pain reliever by her patients, following a prominent public figure's advice against its use during pregnancy. Both national and international medical communities have dismissed these comments as lacking evidence.
Relieving Pregnancy Pains Safely
Paracetamol, also known as acetaminophen, is the only pain reliever currently recommended for pregnant women. Medical professionals advise expectant mothers to use the smallest dosage for the shortest time necessary to manage pain and fever during pregnancy. If left untreated, these conditions could pose risks to both the pregnant women and their babies.
The scientists carried out a comprehensive review and meta-analysis of existing data, examining 43 studies for quality and bias using a standard tool.
Comparative Studies and Genetic Factors
The researchers paid special attention to studies involving children born to the same mother who took paracetamol during one pregnancy but not during another. This approach takes into account shared genetic factors and family environments that could potentially be linked to autism or other studied conditions.
Though there were only three studies of this kind, they were extensive, covering more than 260,000 children assessed for autism, and around 335,000 and 405,000 children for ADHD and intellectual disabilities, respectively.
Addressing Bias in Research
The studies revealed no significant link between the use of the medication and any of the conditions studied. This finding held true even when the results from all of the high-quality studies assessed were combined, the authors reported.
The lead researcher stated that much of the research suggesting a potential link, including a review of 46 studies cited by officials, was susceptible to bias or confounding factors that her team's review had accounted for.
A professor of Translational Neuroscience at a renowned London-based college, who did not participate in the research, lauded the study, expressing hope that the results would put the issue to rest.
